Evaluation of the Aulea Veloxion™ Disposable Resectoscope System for Operational Efficiency in Surgical Management of Benign Prostatic Hyperplasia (BPH)

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexMale

Age30-70

SponsorChinese University of Hong Kong

About this trial

Prospective, single-arm, single-site, post-market device study; all procedures use Veloxion™ per IFU.

Age 30-70 years old with symptomatic BPH.

Prostate volume 20-120 mL (TRUS/MRI/US)

Suitable for endoscopic resection/vaporization per device IFU.

Able to consent and comply with follow-up to 1 month.

Known/suspected prostate cancer requiring oncologic management.

Prior prostate surgery impacting urethral anatomy within 12 months.

Prior implant affecting urethral anatomy.

Active UTI or untreated bacteriuria pre-op.

20 Participants

are divided into 1 treatment group

Chinese University of Hong Kong

Lead sponsor